PL2167042T3 - Kompozycje farmaceutyczne w aerozolu zawierające flutykazon - Google Patents

Kompozycje farmaceutyczne w aerozolu zawierające flutykazon

Info

Publication number
PL2167042T3
PL2167042T3 PL08762620T PL08762620T PL2167042T3 PL 2167042 T3 PL2167042 T3 PL 2167042T3 PL 08762620 T PL08762620 T PL 08762620T PL 08762620 T PL08762620 T PL 08762620T PL 2167042 T3 PL2167042 T3 PL 2167042T3
Authority
PL
Poland
Prior art keywords
fluticasone
aerosol compositions
pharmaceutical aerosol
pharmaceutical
compositions
Prior art date
Application number
PL08762620T
Other languages
English (en)
Inventor
Paul Flanders
James Thompson
Original Assignee
Generics Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics Uk Ltd filed Critical Generics Uk Ltd
Publication of PL2167042T3 publication Critical patent/PL2167042T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08762620T 2007-06-27 2008-06-27 Kompozycje farmaceutyczne w aerozolu zawierające flutykazon PL2167042T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0712454.8A GB0712454D0 (en) 2007-06-27 2007-06-27 Pharmaceutical compositions
EP08762620.6A EP2167042B1 (en) 2007-06-27 2008-06-27 Pharmaceutical aerosol compositions comprising fluticasone
PCT/GB2008/050518 WO2009001144A2 (en) 2007-06-27 2008-06-27 Pharmaceutical aerosol compositions comprising fluticasone

Publications (1)

Publication Number Publication Date
PL2167042T3 true PL2167042T3 (pl) 2016-02-29

Family

ID=38420793

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08762620T PL2167042T3 (pl) 2007-06-27 2008-06-27 Kompozycje farmaceutyczne w aerozolu zawierające flutykazon

Country Status (9)

Country Link
US (1) US9526790B2 (pl)
EP (1) EP2167042B1 (pl)
AU (1) AU2008269528B2 (pl)
CA (1) CA2694238C (pl)
ES (1) ES2554984T3 (pl)
GB (1) GB0712454D0 (pl)
PL (1) PL2167042T3 (pl)
PT (1) PT2167042E (pl)
WO (1) WO2009001144A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3111682A1 (en) * 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
ES2877575T3 (es) * 2016-09-19 2021-11-17 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende salmeterol
US12514995B2 (en) 2021-02-15 2026-01-06 Glenmark Pharmaceuticals Limited Metered dose inhalers of fluticasone or an ester thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1201114A (en) 1980-02-15 1986-02-25 Gordon H. Phillipps Androstane carbothioates
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE69124374T2 (de) 1990-06-29 1997-06-19 Fisons Plc, Ipswich, Suffolk Druckaerosolzusammensetzung
US5182097A (en) 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
ES2180592T3 (es) 1991-06-10 2003-02-16 Schering Corp Formulaciones en aerosol libres de clorofluorocarbonos.
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressurised aerosol compositions
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
DE69205177T2 (de) 1991-12-12 1996-03-21 Glaxo Group Ltd., Greenford, Middlesex Pharmazeutische Aerosolformulierung.
GB9419536D0 (en) 1994-09-28 1994-11-16 Glaxo Inc Medicaments
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6261539B1 (en) 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
FR2798290B1 (fr) * 1999-09-11 2003-09-12 Glaxo Group Ltd Formulation pharmaceutique de propionate de fluticasone
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
WO2003063843A1 (en) 2002-02-01 2003-08-07 Astrazeneca Ab Composition for inhalation
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US20040208833A1 (en) 2003-02-04 2004-10-21 Elan Pharma International Ltd. Novel fluticasone formulations
GB0328630D0 (en) * 2003-12-10 2004-01-14 Medpharm Ltd Metered dose inhalation preparations
DE602004019232D1 (de) * 2004-11-19 2009-03-12 Kpss Kao Gmbh Aerosolprodukt zur Haarbehandlung enthaltend amphoterische sowie nichtionische Polymere
US20070065374A1 (en) * 2005-03-16 2007-03-22 Elan Pharma International Limited Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
AU2006226887A1 (en) * 2005-03-23 2006-09-28 Elan Pharma International Limited Nanoparticulate corticosteroid and antihistamine formulations
DE102006053374A1 (de) 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz

Also Published As

Publication number Publication date
AU2008269528A1 (en) 2008-12-31
WO2009001144A3 (en) 2009-03-19
AU2008269528B2 (en) 2013-05-16
WO2009001144A2 (en) 2008-12-31
CA2694238A1 (en) 2008-12-31
US9526790B2 (en) 2016-12-27
US20110020244A1 (en) 2011-01-27
CA2694238C (en) 2013-02-12
ES2554984T3 (es) 2015-12-28
EP2167042B1 (en) 2015-09-09
EP2167042A2 (en) 2010-03-31
GB0712454D0 (en) 2007-08-08
PT2167042E (pt) 2015-12-21

Similar Documents

Publication Publication Date Title
IL247741A0 (en) pharmaceutical preparations
EP2001498A4 (en) PHARMACEUTICAL COMPOSITIONS
IL194176A0 (en) Pharmaceutical compositions
GB0713625D0 (en) Pharmaceutical compositions
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
PL2124556T3 (pl) Kompozycje farmaceutyczne
EP2222313A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
SI2966175T1 (sl) Farmacevtski sestavki vsebujoči korteksolon-17-alfa-propionat
IL200885A (en) A history of mannich-based compounds and pharmacological preparations including them
ZA201103347B (en) Pharmaceutical aerosol composition
GB0707127D0 (en) Pharmaceutical compositions
GB0608724D0 (en) Novel Pharmaceutical Compositions
EP2146695A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0709811D0 (en) Pharmaceutical compositions
GB0610322D0 (en) Novel pharmaceutical compositions
PL2167042T3 (pl) Kompozycje farmaceutyczne w aerozolu zawierające flutykazon
GB0716907D0 (en) Pharmaceutical powder compositions
GB2454923B (en) Pharmaceutical compositions
IL201394A0 (en) Niacin - based pharmaceutical compositions
HU0700755D0 (en) Pharmaceutical compositions containing capsaicionid
GB0706657D0 (en) Pharmaceutical compositions
GB0709603D0 (en) Pharmaceutical compositions
GB0621623D0 (en) Pharmaceutical compositions
GB0611079D0 (en) Pharmaceutical compositions